What is this study about?
CAMH is currently recruiting participants with IBD for a brain imaging study! Many people with inflammatory bowel disease (IBD) experience symptoms of depression including depressed mood, sleep disturbance, trouble enjoying things and low energy. It is thought that this can be caused by the inflammation in IBD spreading to the brain.
At CAMH, we developed a brain scan to detect inflammation, the body’s response to injury and infections. We have used this brain scan to study many different illnesses, but it is new for use in IBD. If our study shows that this type of brain scan detects changes in IBD, our hope is that the results will help develop new treatments specifically for depression caused by inflammation.
Your Role in this Study
Participation in this study will include in-person visits that are done at CAMH. The first visit will be done to assess eligibility to participate in the study. The other visits will include one to two PET scans with blood sampling, one to two MRI scans, and questionnaires.
Who can Participate?
The eligibility criteria is:
• Have a diagnosis for IBD (Crohn’s disease or ulcerative colitis)
• Be otherwise in good physical health
• Be age 18 – 65, non-smoker
• No history of neurological illness
• Not currently taking street drugs
• Not currently pregnant or breastfeeding
Compensation will be provided.
For more information, please contact our study team at email@example.com or 416-535-8501 x 30741. Voicemails will be returned within one week.
The security of information sent by e-mail cannot be guaranteed. Please do not communicate personal sensitive information by e-mail. Please do not use e-mail to communicate emergency or urgent health matters.
For information about programs and services at CAMH, please visit www.camh.ca or call 416-535-8501 (or 1-800-463-6273).
This study has been approved by the Centre for Addiction and Mental Health Research Ethics Board
Centre of Addiction and Mental Health (CAMH)